Company Filing History:
Years Active: 2008-2010
Title: Innovations by Allan R. Shepard in Ocular Disorder Treatments
Introduction
Allan R. Shepard is a notable inventor based in Fort Worth, TX (US), recognized for his contributions to the field of ocular disorders. He holds a total of 4 patents, showcasing his innovative approach to medical treatments.
Latest Patents
Among his latest patents, Shepard has developed a method for RNA interference (RNAi) inhibition of connective tissue growth factor (CTGF) for the treatment of ocular disorders. This invention targets the mRNA expression of CTGF, which is implicated in various ocular conditions such as glaucoma, macular degeneration, diabetic retinopathy, choroidal neovascularization, proliferative vitreoretinopathy, and wound healing. The treatment involves administering interfering RNAs that effectively inhibit CTGF expression, providing a promising avenue for managing these disorders.
Career Highlights
Shepard's career is marked by his work at Alcon, Inc., a leading company in eye care. His innovative research and development efforts have significantly advanced the understanding and treatment of ocular diseases.
Collaborations
Throughout his career, Shepard has collaborated with esteemed colleagues, including Iok-Hou Pang and Abbot F. Clark, contributing to the advancement of ocular health technologies.
Conclusion
Allan R. Shepard's work in RNAi inhibition for ocular disorders exemplifies the impact of innovation in medical treatments. His patents reflect a commitment to improving patient outcomes in the field of eye care.